Liquid formulations of bone morphogenetic proteins are provided for prolonged use at elevated temperatures. More specifically, the invention relates to liquid formulations comprising rhGDF-5, trehalose, and one or more biocompatible excipients that provide stability to the protein for at least 30 days at temperatures up to body temperature.

 
Web www.patentalert.com

< Avermectin and avermectin monosaccharide derivatives substituted in the 4''-or 4'-position having pesticidal properties

> Hepatocyte growth factor receptor splice variants and methods of using same

> Salts of avermectins substituted in the 4''-position and having pesticidal properties
~ 00587